Research & Literature

Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.

Cohen O, Locketz G, Hershko AY, et al.

Rheumatology international 2015; (35(11)):1937-41 doi:10.1007/s00296-015-3325-y.

Patient with FMF and Triple MEFV Gene Mutations.

Salehzadeh F, Fathi A

Medical archives (Sarajevo, Bosnia and Herzegovina) 2015; (69(4)):269-70 doi:10.5455/medarh.2015.69.269-270.

Frequency of mutations in Mediterranean fever gene, with gender and genotype-phenotype correlations in a Turkish population.

Coşkun S, Kurtgöz S, Keskin E, et al.

Journal of genetics 2015; (94(4)):629-35 doi:10.1007/s12041-015-0568-z.

[INTERLEUKIN 1 INHIBITORS--A NEW HORIZON IN THE TREATMENT OF FAMILIAL MEDITERRANEAN FEVER].

Shouval R, Livneh A, Ben-Zvi I

Harefuah 2015; (154(11)):716-9, 741.

The role of neutrophil lymphocyte ratio to leverage the differential diagnosis of familial Mediterranean fever attack and acute appendicitis.

Kucuk A, Erol MF, Senel S, et al.

The Korean journal of internal medicine 2016; (31(2)):386-91 doi:10.3904/kjim.2015.039.

Is Turkish MEFV Mutations Spectrum Different Among Regions?

Yilmaz G, Senes M, Kayalp D, Yucel D

Journal of clinical laboratory analysis 2016; (30(5)):641-4 doi:10.1002/jcla.21915.

Update on Pyrin Functions and Mechanisms of Familial Mediterranean Fever.

Manukyan G, Aminov R

Frontiers in microbiology 2016; (7()):456 doi:10.3389/fmicb.2016.00456.

Sacroiliitis and Polyarteritis Nodosa in a Patient with Familial Mediterranean Fever.

Ugan Y, Doğru A, Şencan H, et al.

Case reports in medicine 2016; (2016()):5134546 doi:10.1155/2016/5134546.

A case of familial Mediterranean fever who complained of periodic fever and abdominal pain diagnosed by MEFV gene analysis.

Ogita C, Matsui K, Kisida D, et al.

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2016; (39(1)):72-7 doi:10.2177/jsci.39.72.

Mutational Spectrum of the MEFV Gene in AA Amyloidosis Associated With Familial Mediterranean Fever.

Nursal AF, Tekcan A, Kaya SU, et al.

Iranian journal of kidney diseases 2016; (10(3)):107-12.

[Familial Mediterranean fever – an important disease in a globalised world].

Wekell P, Karlsson A, Fasth A, Berg S

Lakartidningen 2016; (113()).

Prevalence of common MEFV mutations and carrier frequencies in a large cohort of Iranian populations.

Beheshtian M, Izadi N, Kriegshauser G, et al.

Journal of genetics 2016; (95(3)):667-74 doi:10.1007/s12041-016-0682-6.

Case report: recurrent abdominal symptoms in a child with panhypopituitarism - there is always a differential.

Olbrich L, Schmidt E, Mayatepek E, Vogel M

International journal of pediatric endocrinology 2016; (2016()):18 doi:10.1186/s13633-016-0037-3.

Concordance between CRP and SAA in familial Mediterranean fever during attack-free period: A study of 218 patients.

Stankovic Stojanovic K, Hentgen V, Fellahi S, et al.

Clinical biochemistry 2017; (50(4-5)):206-209 doi:10.1016/j.clinbiochem.2016.11.008.

Approach to the patients with inadequate response to colchicine in familial Mediterranean fever.

Gül A

Best practice & research. Clinical rheumatology 2016; (30(2)):296-303 doi:10.1016/j.berh.2016.09.001.

The M694I/M694I genotype: A genetic risk factor of AA-amyloidosis in a group of Algerian patients with familial Mediterranean fever.

Ait-Idir D, Djerdjouri B, Bouldjennet F, et al.

European journal of medical genetics 2017; (60(3)):149-153 doi:10.1016/j.ejmg.2016.12.003.

Familial Mediterranean fever presenting as fever of unknown origin in Korea.

Lee JH, Kim JH, Shim JO, et al.

Korean journal of pediatrics 2016; (59(Suppl 1)):S53-S56 doi:10.3345/kjp.2016.59.11.S53.

Serum Amyloid A Level in Egyptian Children with Familial Mediterranean Fever.

Lofty HM, Marzouk H, Farag Y, et al.

International journal of rheumatology 2016; (2016()):7354018 doi:10.1155/2016/7354018.

[Role of genetics in familial Mediterranean fever].

Kallinich T, Orak B, Wittkowski H

Zeitschrift fur Rheumatologie 2017; (76(4)):303-312 doi:10.1007/s00393-017-0265-9.

A survey of resistance to colchicine treatment for French patients with familial Mediterranean fever.

Corsia A, Georgin-Lavialle S, Hentgen V, et al.

Orphanet journal of rare diseases 2017; (12(1)):54 doi:10.1186/s13023-017-0609-1.

Canakinumab for the treatment of familial Mediterranean fever.

Ozdogan H, Ugurlu S

Expert review of clinical immunology 2017; (13(5)):393-404 doi:10.1080/1744666X.2017.1313116.

Tofacitinib suppresses disease activity and febrile attacks in a patient with coexisting rheumatoid arthritis and familial Mediterranean fever.

Gök K, Cengiz G, Erol K, Ozgocmen S

Acta reumatologica portuguesa 2017; (42(1)):88-90.

Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management.

Özen S, Batu ED, Demir S

Frontiers in immunology 2017; (8()):253 doi:10.3389/fimmu.2017.00253.

A retrospective analysis of 7 cases of familial mediterranean fever.

Ogita C, Matsui K, Kisida D, et al.

Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology 2017; (40(1)):21-27 doi:10.2177/jsci.40.21.

Familial Mediterranean fever, review of the literature.

Alghamdi M

Clinical rheumatology 2017; (36(8)):1707-1713 doi:10.1007/s10067-017-3715-5.

The detection of a novel insertion mutation in exon 2 of the MEFV gene associated with familial mediterranean fever in a moroccan family.

Mejtoute T, Sayel H, El-Akhal J, et al.

Human genome variation 2017; (4()):17023 doi:10.1038/hgv.2017.23.

Cold Exposure Related Fever with an Mediterranean Fever (MEFV) Gene Mutation.

Kumei S, Nozu T, Ohira M, et al.

Internal medicine (Tokyo, Japan) 2017; (56(16)):2233-2236 doi:10.2169/internalmedicine.8274-16.

Familial Mediterranean Fever Is Associated With Increased Mortality After Kidney Transplantation-A 19 Years' Single Center Experience.

Green H, Lichtenberg S, Rahamimov R, et al.

Transplantation 2017; (101(10)):2621-2626 doi:10.1097/TP.0000000000001681.

Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.

Haj Yahia S, Ben Zvi I, Livneh A

Rheumatology international 2018; (38(1)):141-147 doi:10.1007/s00296-017-3823-1.

Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.

Jamilloux Y, Lefeuvre L, Magnotti F, et al.

Rheumatology (Oxford, England) 2018; (57(1)):100-111 doi:10.1093/rheumatology/kex373.

Cardiac disease in familial Mediterranean fever.

Erken E, Erken E

Rheumatology international 2018; (38(1)):51-58 doi:10.1007/s00296-017-3853-8.

Long-term follow-up of paediatric MEFV carriers.

Makay B, Gülez N

Clinical rheumatology 2018; (37(6)):1683-1687 doi:10.1007/s10067-017-3883-3.

MEFV gene testing may guide physicians for early diagnosis of familial Mediterranean fever.

Tezcan ME, Avci M, Mercan R, et al.

International journal of rheumatic diseases 2018; (21(7)):1452-1457 doi:10.1111/1756-185X.13258.

Fatigue in pediatric patients with familial Mediterranean fever.

Özdel S, Özçakar ZB, Cakar N, et al.

Modern rheumatology 2018; (28(6)):1016-1020 doi:10.1080/14397595.2018.1427459.

Atypical familial Mediterranean fever developed in a long-term hemodialysis patient.

Makino T, Ohara Y, Kobayashi N, et al.

Hemodialysis international. International Symposium on Home Hemodialysis 2018; (22(2)):E19-E22 doi:10.1111/hdi.12628.

Canakinumab treatment in renal transplant recipients with familial Mediterranean fever.

Yildirim T, Yilmaz R, Uzerk Kibar M, Erdem Y

Journal of nephrology 2018; (31(3)):453-455 doi:10.1007/s40620-018-0475-5.

A rare cause of fever in an adult: a case of familial Mediterranean fever.

Erdem I, Saritas F, Karaali R, et al.

International medical case reports journal 2018; (11()):37-40 doi:10.2147/IMCRJ.S148205.

Two cases of periodic fever syndrome with coexistent mevalonate kinase and Mediterranean fever gene mutations.

Çakan M, Aktay-Ayaz N, Keskindemirci G, Karadağ ŞG

The Turkish journal of pediatrics 2017; (59(4)):467-470.

Profile of renal AA amyloidosis in older and younger individuals: a single-centre experience.

Erdogmus S, Kendi Celebi Z, Akturk S, et al.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 2018; (25(2)):115-119 doi:10.1080/13506129.2018.1474733.

GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever.

Kanneganti A, Malireddi RKS, Saavedra PHV, et al.

The Journal of experimental medicine 2018; (215(6)):1519-1529 doi:10.1084/jem.20172060.

Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients: A Single-Center Real-Life Study.

Babaoglu H, Varan O, Kucuk H, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2020; (26(1)):7-13 doi:10.1097/RHU.0000000000000873.

Protracted febrile myalgia as a challenging manifestation of familial Mediterranean fever: case-based review.

Yıldırım DG, Bakkaloglu SA, Buyan N

Rheumatology international 2019; (39(1)):147-152 doi:10.1007/s00296-018-4163-5.

Exon 2: Is it the good police in familial mediterranean fever?

Bilge ŞY, Solmaz D, Şenel S, et al.

European journal of rheumatology 2019; (6(1)):34-37 doi:10.5152/eurjrheum.2018.18115.

IL1-blocking therapy in colchicine-resistant familial Mediterranean fever.

Köhler BM, Lorenz HM, Blank N

European journal of rheumatology 2018; (5(4)):230-234 doi:10.5152/eurjrheum.2018.18036.

Secondary amyloidosis associated with heroin use and recurrent infections - A case report.

Mani D

Annals of medicine and surgery (2012) 2019; (37()):38-41 doi:10.1016/j.amsu.2018.11.013.

Familial Mediterranean Fever.

Ozdogan H, Ugurlu S

Presse medicale (Paris, France : 1983) 2019; (48(1 Pt 2)):e61-e76 doi:10.1016/j.lpm.2018.08.014.

Intima media thickness as an early predictor of atherosclerosis in Egyptian children with familial Mediterranean fever.

Mahmoud SSE, Ismail NA, Farag YM, et al.

Archives of medical sciences. Atherosclerotic diseases 2018; (3()):e106-e111 doi:10.5114/amsad.2018.77545.

Arterial stiffness in Familial Mediterranean Fever: correlations with disease-related parameters and colchicine treatment.

Sgouropoulou V, Stabouli S, Trachana M

Clinical rheumatology 2019; (38(9)):2577-2584 doi:10.1007/s10067-019-04601-6.

Phenotypes and genotypes of Chinese adult patients with systemic autoinflammatory diseases.

Hua Y, Wu D, Shen M, et al.

Seminars in arthritis and rheumatism 2019; (49(3)):446-452 doi:10.1016/j.semarthrit.2019.05.002.

Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series.

Sendogan DO, Saritas H, Kumru G, et al.

Transplantation proceedings 2019; (51(7)):2292-2294 doi:10.1016/j.transproceed.2019.03.049.

The Value of Serum Amyloid A Levels in Familial Mediterranean Fever to Identify Occult Inflammation During Asymptomatic Periods.

Çakan M, Karadağ ŞG, Tanatar A, et al.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(1)):1-4 doi:10.1097/RHU.0000000000001134.

Familial Mediterranean Fever: an unusual cause of liver disease.

Maggio MC, Castiglia M, Corsello G

Italian journal of pediatrics 2019; (45(1)):121 doi:10.1186/s13052-019-0712-0.

Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients.

Magnotti F, Lefeuvre L, Benezech S, et al.

EMBO molecular medicine 2019; (11(11)):e10547 doi:10.15252/emmm.201910547.

Prevalence of MEFV gene mutations in a large cohort of patients with suspected familial Mediterranean fever in Central Anatolia.

Yildirim ME, Kurtulgan HK, Ozdemir O, et al.

Annals of Saudi medicine 2019; (39(6)):382-387 doi:10.5144/0256-4947.2019.382.

FMF is not always "fever": from clinical presentation to "treat to target".

Maggio MC, Corsello G

Italian journal of pediatrics 2020; (46(1)):7 doi:10.1186/s13052-019-0766-z.

Red Cell Distribution Width (RDW) as a Marker of Subclinical Inflammation in Children with Familial Mediterranean Fever.

Marzouk H, Mostafa N, Khalifa I, et al.

Current rheumatology reviews 2020; (16(4)):298-303 doi:10.2174/1573397116666200312142709.

Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever.

Cakan M, Karadag SG, Ayaz NA

Northern clinics of Istanbul 2020; (7(1)):78-80 doi:10.14744/nci.2019.38243.

Familial Mediterranean fever-associated renal amyloidosis: case report and review of the literature.

Andronesi AG, Ismail G, Gherghiceanu M, et al.

Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 2019; (60(4)):1299-1303.

The MEFV gene and its association with familial Mediterranean fever, severe atopy, and recurrent respiratory tract infections.

Celiksoy MH, Dogan C, Erturk B, et al.

Allergologia et immunopathologia 2020; (48(5)):430-440 doi:10.1016/j.aller.2019.12.010.

Clinical Manifestations and Outcomes of Colchicine Poisoning Cases; a Cross Sectional Study.

Rahimi M, Alizadeh R, Hassanian-Moghaddam H, et al.

Archives of academic emergency medicine 2020; (8(1)):e53.

Systemic autoinflammatory diseases: Clinical state of the art.

Georgin-Lavialle S, Ducharme-Benard S, Sarrabay G, et al.

Best practice & research. Clinical rheumatology 2020; (34(4)):101529 doi:10.1016/j.berh.2020.101529.

Coexisting Diseases in Patients with Familial Mediterranean Fever.

Salehzadeh F, Enteshari Moghaddam A

Open access rheumatology : research and reviews 2020; (12()):65-71 doi:10.2147/OARRR.S252071.

The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review.

Hentgen V, Vinit C, Fayand A, Georgin-Lavialle S

Frontiers in immunology 2020; (11()):971 doi:10.3389/fimmu.2020.00971.

The importance of Mediterranean fever gene in familial Mediterranean fever.

Kehribar DY, Özgen M

European journal of rheumatology 2020; doi:10.5152/eurjrheum.2020.20107.

Effect of Low-dose ColchiciNe on the InciDence of Atrial Fibrillation in Open Heart Surgery Patients: END-AF Low Dose Trial.

Tabbalat RA, Alhaddad I, Hammoudeh A, et al.

The Journal of international medical research 2020; (48(7)):300060520939832 doi:10.1177/0300060520939832.

The pyrin inflammasome and the Yersinia effector interaction.

Malik HS, Bliska JB

Immunological reviews 2020; (297(1)):96-107 doi:10.1111/imr.12907.

Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review

Tufan A, Lachmann HJ

Turkish journal of medical sciences 2020; (50(SI-2)):1591-1610 doi:10.3906/sag-2008-11.

Defining colchicine resistance/intolerance in patients with familial Mediterranean fever: a modified-Delphi consensus approach.

Özen S, Sag E, Ben-Chetrit E, et al.

Rheumatology (Oxford, England) 2021; (60(8)):3799-3808 doi:10.1093/rheumatology/keaa863.

Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials.

Andreis A, Imazio M, Avondo S, et al.

Journal of cardiovascular medicine (Hagerstown, Md.) 2021; (22(8)):637-644 doi:10.2459/JCM.0000000000001157.

Presentation of a new mutation in FMF and evaluating the frequency of distribution of the MEFV gene mutation in our region with clinical findings.

Arpacı A, Doğan S, Erdoğan HF, et al.

Molecular biology reports 2021; (48(3)):2025-2033 doi:10.1007/s11033-020-06040-y.

Non-adherence to colchicine treatment is a common misevaluation in familial Mediterranean fever

Tekgöz E, Çolak S, Çınar Fİ, et al.

Turkish journal of medical sciences 2021; (51(5)):2357-2363 doi:10.3906/sag-2102-328.

Discontinuation of Colchicine Therapy in Children With Familial Mediterranean Fever.

Aviel YB, Rawan S, Fahoum S, et al.

The Journal of rheumatology 2021; (48(11)):1732-1735 doi:10.3899/jrheum.201158.

Long-term safety and efficacy of anakinra and canakinumab in patients with familial Mediterranean fever: a single-centre real-life study with 101 patients.

Atas N, Eroglu GA, Sodan HN, et al.

Clinical and experimental rheumatology 2021; (39 Suppl 132(5)):30-36 doi:10.55563/clinexprheumatol/815tdt.

M680I/M694V Heterozygous Mutation in Early Onset Familial Mediterranean Fever.

Darwish WM, Darwish SB, Darwish MB, Darwish BF

Journal of medical cases 2021; (12(9)):351-354 doi:10.14740/jmc3747.

The analysis of genotype-phenotype correlation in familial Mediterranean fever.

Ozturk K, Cakan M

Pediatrics international : official journal of the Japan Pediatric Society 2022; (64(1)):e15017 doi:10.1111/ped.15017.

Amyloidosis and Glomerular Diseases in Familial Mediterranean Fever.

Siligato R, Gembillo G, Calabrese V, et al.

Medicina (Kaunas, Lithuania) 2021; (57(10)) doi:10.3390/medicina57101049.

Interventions for reducing inflammation in familial Mediterranean fever.

Yin X, Tian F, Wu B, Xu T

The Cochrane database of systematic reviews 2022; (3()):CD010893 doi:10.1002/14651858.CD010893.pub4.

Down-regulated Th17 cells in a patient with familial Mediterranean fever associated with amyloid A amyloidosis in the treatment of canakinumab.

Goto T, Miyazaki Y, Nakayamada S, et al.

Modern rheumatology case reports 2023; (7(1)):237-242 doi:10.1093/mrcr/rxac031.

The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease.

Giat E, Ben-Zvi I, Lidar M, Livneh A

International journal of molecular sciences 2022; (23(7)) doi:10.3390/ijms23073956.

Colchicine resistance: Associated factors and its effect on health-related quality of life in patients with familial Mediterranean fever.

Erdem Gürsoy D, Gezer HH, Öz N, et al.

International journal of rheumatic diseases 2022; (25(11)):1239-1245 doi:10.1111/1756-185X.14407.

IL-1 inhibition in familial Mediterranean fever: clinical outcomes and expectations.

Kharouf F, Tsemach-Toren T, Ben-Chetrit E

Clinical and experimental rheumatology 2022; (40(8)):1567-1574 doi:10.55563/clinexprheumatol/obb2ds.

Can RDW be used as a screening test for subclinical inflammation in children with FMF? Is RDW related to MEFV gene mutations?

Parmaksız G, Noyan ZA

Clinical rheumatology 2023; (42(1)):197-202 doi:10.1007/s10067-022-06358-x.

Acute Recurrent Pericarditis as the Inaugural Manifestation of Familial Mediterranean Fever.

Attout H, Amichi S, Bouhamla H

European journal of case reports in internal medicine 2022; (9(9)):003542 doi:10.12890/2022_003542.

Examining the Characteristics of Colchicine-Induced Myelosuppression in Clinical Cases: A Systematic Review.

Sim BL, Sim BZ, Tunbridge M, et al.

The Journal of rheumatology 2023; (50(3)):400-407 doi:10.3899/jrheum.220524.

CDC42 regulates PYRIN inflammasome assembly.

Spel L, Zaffalon L, Hou C, et al.

Cell reports 2022; (41(7)):111636 doi:10.1016/j.celrep.2022.111636.

Colchicine treatment can be discontinued in a selected group of pediatric FMF patients.

Cohen K, Spielman S, Semo-Oz R, et al.

Pediatric rheumatology online journal 2023; (21(1)):2 doi:10.1186/s12969-022-00780-w.

French practical guidelines for the diagnosis and management of AA amyloidosis.

Georgin-Lavialle S, Savey L, Buob D, et al.

La Revue de medecine interne 2023; (44(2)):62-71 doi:10.1016/j.revmed.2022.12.004.

A recurrent side-changing febrile pleural effusion revealing familial Mediterranean fever: a case report.

Mejri I, Saidane A, Boubaker N, et al.

The Pan African medical journal 2022; (43()):121 doi:10.11604/pamj.2022.43.121.33324.

Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy.

Aiello A, Mariano EE, Prada M, et al.

Journal of market access & health policy 2023; (11(1)):2176091 doi:10.1080/20016689.2023.2176091.

Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation.

Chirita D, Bronnec P, Magnotti F, et al.

Cell death & disease 2023; (14(3)):213 doi:10.1038/s41419-023-05745-9.

Atypical Familial Mediterranean Fever Presenting with Recurrent Upper Back Pain: A Case Report.

Matsumoto H, Saito K, Sumichika Y, et al.

The Tohoku journal of experimental medicine 2023; (260(2)):165-169 doi:10.1620/tjem.2023.J030.

Investigation of different genomic variants in familial Mediterranean fever cases with monoallelic MEFV mutation.

Kocabey M, Cankaya T, Bayram MT, et al.

Clinical and experimental rheumatology 2023; (41(10)):2017-2026 doi:10.55563/clinexprheumatol/2z3l1u.

Familial Mediterranean Fever-Related Amyloidosis in Turkey: A Need for a Familial Mediterranean Fever Registry.

Helvaci O, Yasar E

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2023; (21(Suppl 2)):101-104 doi:10.6002/ect.IAHNCongress.24.

Efficacy and safety of anti-interleukin-1 in children with colchicine-resistant familial Mediterranean fever.

Erkilet HK, Gezgin Yildirim D, Esmeray P, Söylemezoğlu O

Pediatrics international : official journal of the Japan Pediatric Society 2023; (65(1)):e15588 doi:10.1111/ped.15588.

Gray zone in the spectrum of autoinflammatory diseases: familial Mediterranean fever accompanying periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome: single-center experience.

Konte EK, Haslak F, Yildiz M, et al.

European journal of pediatrics 2023; (182(12)):5473-5482 doi:10.1007/s00431-023-05209-4.

The clinical role of anakinra in the armamentarium against familial Mediterranean fever.

Parlar K, Ates MB, Egeli BH, Ugurlu S

Expert review of clinical immunology 2024; (20(5)):441-453 doi:10.1080/1744666X.2023.2299230.

Unraveling the genome: Familial Mediterranean fever.

Koehler AW

Journal of the American Association of Nurse Practitioners 2024; (36(1)):3-5 doi:10.1097/JXX.0000000000000959.

Familial Mediterranean Fever Complicated By Massive Cardiac Tamponade.

Melo L, Patail H, Gautam G, et al.

Cureus 2023; (15(12)):e50137 doi:10.7759/cureus.50137.

The pyrin inflammasome, a leading actor in pediatric autoinflammatory diseases.

La Bella S, Di Ludovico A, Di Donato G, et al.

Frontiers in immunology 2023; (14()):1341680 doi:10.3389/fimmu.2023.1341680.

Experimental models in Familial Mediterranean Fever (FMF): Insights into pathophysiology and therapeutic strategies.

Mezher N, Mroweh O, Karam L, et al.

Experimental and molecular pathology 2024; (135()):104883 doi:10.1016/j.yexmp.2024.104883.

A Case of Protracted Febrile Myalgia Syndrome with Atypical Course and Severe Asymmetric Loss of Muscle Strength.

Deniz R, Mandacı A, Gerdan I, et al.

Mediterranean journal of rheumatology 2023; (34(4)):550-554 doi:10.31138/mjr.300723.aco.

[Familial mediterranean fever].

Vinit C

La Revue du praticien 2023; (73(8)):843-849.

Predicting genetic risk factors for AA amyloidosis in Algerian patients with familial Mediterranean fever.

Ait-Idir D, Djerdjouri B, Latreche K, et al.

Molecular genetics and genomics : MGG 2024; (299(1)):25 doi:10.1007/s00438-024-02133-6.

Factors triggering familial mediterranean fever attacks, do they really exist?

Parlar K, Ates MB, Onal ME, et al.

Internal and emergency medicine 2024; (19(4)):1007-1013 doi:10.1007/s11739-024-03576-w.

Recurrent Bouts of Fever and Transient Hydrosalpinx Manifested in a Female Carrying MEFV G304R Gene Variant: A Case Report.

Aikawa T, Yoshida S, Saruwatari K, et al.

Cureus 2024; (16(2)):e55188 doi:10.7759/cureus.55188.

Amyopathic dermatomyositis may be on the spectrum of autoinflammatory disease: A clinical review.

Sharmeen S, Christopher-Stine L, Salvemini JN, et al.

Rheumatology and immunology research 2024; (5(1)):42-48 doi:10.1515/rir-2024-0005.

The significance of carrying MEFV variants in symptomatic and asymptomatic individuals.

Ben-Chetrit E, Touitou I

Clinical genetics 2024; (106(3)):217-223 doi:10.1111/cge.14566.

Heterozygous MEFV Mutation Leading to Renal Failure: A Case Study.

El Gazzane S, Ichane A, Nahi C, et al.

Global pediatric health 2024; (11()):2333794X241274752 doi:10.1177/2333794X241274752.

Diagnostic delays in familial Mediterranean fever: a Juvenile Inflammatory Rheumatism (JIR) cohort study.

Bourguiba R, Deshayes S, Amaryan G, et al.

Rheumatology international 2024; (44(12)):3107-3111 doi:10.1007/s00296-024-05706-1.

Familial Mediterranean Fever in Pregnancy.

Davidson A, Kuller JA, Dotters-Katz SK, Wood RL

Obstetrical & gynecological survey 2024; (79(10)):611-616 doi:10.1097/OGX.0000000000001316.

Elderly-onset Familial Mediterranean Fever Carrying MEFV Exon 10 Variants in a Japanese Patient.

Fujita Y, Ogawa S, Sumichika Y, et al.

Internal medicine (Tokyo, Japan) 2025; (64(10)):1595-1598 doi:10.2169/internalmedicine.4463-24.

Genewise detection of variants in MEFV gene using nanopore sequencing.

Ghukasyan L, Khachatryan G, Sirunyan T, et al.

Frontiers in genetics 2024; (15()):1493295 doi:10.3389/fgene.2024.1493295.

Characteristics of Siblings with Familial Mediterranean Fever: A Single-Center Experience.

Arslanoglu Aydin E, Baglan E, Bagrul İ, et al.

Turkish archives of pediatrics 2025; (60(1)):57-62 doi:10.5152/TurkArchPediatr.2025.24210.

An Autoethnographic Account of Familial Mediterranean Fever: A Turkish Patient's Discovery of Spiritual Meaning.

Yuksel C

Journal of religion and health 2025; (64(5)):3875-3896 doi:10.1007/s10943-025-02253-2.

Familial Mediterranean fever in Romania: a case report and literature review.

Iuhas A, Marinău C, Niulaș L, et al.

Frontiers in pediatrics 2024; (12()):1546387 doi:10.3389/fped.2024.1546387.

Fertility in male patients with familial Mediterranean fever and paternal effect of FMF on pregnancy outcomes and complications.

Parlar K, Azman FN, Sıcakyüz SL, et al.

Internal and emergency medicine 2025; (20(3)):797-803 doi:10.1007/s11739-025-03881-y.

Unexpectedly high prevalence of familial Mediterranean fever in Slovakia.

Jesenak M, Jurkova EM, Bobcakova A, et al.

Clinical and experimental medicine 2025; (25(1)):101 doi:10.1007/s10238-025-01634-x.

Familial Mediterranean Fever; Recent Advances, Future Prospectives.

Romano M, Piskin D, Kul Cinar O, Sag E

Diagnostics (Basel, Switzerland) 2025; (15(7)) doi:10.3390/diagnostics15070813.

Efficacy and Safety of Anakinra in Colchicine-Resistant or -Intolerant Familial Mediterranean Fever: A Single-Center Real-Life Experience.

Ocak T, Köse HN, Yağız B, et al.

Medicina (Kaunas, Lithuania) 2025; (61(5)) doi:10.3390/medicina61050792.

Efficacy and safety of treatments in familial Mediterranean fever and its complications: a systematic review informing the EULAR/PReS recommendations for familial Mediterranean fever.

Sag E, Otón T, Carmona L, Ozen S

Annals of the rheumatic diseases 2025; (84(11)):1909-1927 doi:10.1016/j.ard.2025.05.020.

Accurate Diagnosis of Familial Mediterranean Fever Improved Quality of Life for a Patient and Her Family: A Case Report.

Kurihara M, Igarashi T, Ishii R, et al.

Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2026; (92(6)):480-485 doi:10.1272/jnms.JNMS.2025_92-610.

Familial Mediterranean fever (FMF) complicated by adhesive small bowel obstruction: a diagnostic challenge.

Hassan TH, Sourial K

BMJ case reports 2025; (18(9)) doi:10.1136/bcr-2025-267723.

Familial mediterranean fever and long-term cardiovascular disease burden.

Magen E, Aamar S, Merzon E, et al.

The American journal of medicine 2026; doi:10.1016/j.amjmed.2026.01.006.

Evaluation of the Effect of IL-1 Antagonists on Pituitary Function.

Aktas Koc F, Sariakcali B, Sahin A

International journal of endocrinology 2026; (2026()):8796993 doi:10.1155/ije/8796993.

Genetic, and clinical features in Italian and lebanese subjects with familial mediterranean fever (FMF).

Jaber N, Khalil M, Abdallah H, et al.

European journal of internal medicine 2026; 106756 doi:10.1016/j.ejim.2026.106756.